COMMUNIQUÉS West-GlobeNewswire

Autolus Announces Proposed Public Offering in the United States
08/04/2019
LONDON, April 08, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it intends to [...]
Natus Medical to Hold 2019 First Quarter Financial Results Conference Call on April 25th
08/04/2019
PLEASANTON, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY), a leading provider of medical devices and services, today announced that the Company will release its 2019 first quarter [...]
T2 Biosystems Reports Granting of Inducement Awards
08/04/2019
LEXINGTON, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare [...]
NGM Bio Announces Multiple Presentations at The International Liver Congress™ 2019
08/04/2019
SOUTH SAN FRANCISCO, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (Nasdaq: NGM), a clinical stage biotechnology company focused on harnessing powerful biology to develop transformative [...]
DBV Technologies Announces Closing of Global Offering
08/04/2019
Montrouge, France, April 8, 2019 DBV Technologies (the “Company”) (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the settlement and delivery [...]
DBV Technologies annonce la réalisation de son offre globale
08/04/2019
Montrouge, France, le 8 avril (22h30 CEST), 2019 DBV Technologies (la « Société ») (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique française, annonce ce jour le règlement [...]
Daré Bioscience, Inc. Announces Proposed Public Offering of Common Stock
08/04/2019
SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced that it intends to offer shares of its common stock in an underwritten public [...]
Homology Medicines Announces Proposed Public Offering of Common Stock
08/04/2019
BEDFORD, Mass., April 08, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, today announced that it intends to offer and sell, subject to market and other conditions, $125.0 [...]
Translate Bio Presents Preclinical Data Supporting MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency at the Society for Inherited Metabolic Disorders (SIMD) Annual Meeting
08/04/2019
-- MRT5201 was efficiently delivered to the liver of a mouse model of OTC deficiency -- -- Preclinical data demonstrated a single IV dose of MRT5201 was sufficient to protect against hyperammonemia for up to 4 weeks -- [...]
Alder BioPharmaceuticals® Appoints Nadia Dac as Chief Commercial Officer
08/04/2019
BOTHELL, Wash., April 08, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Silk Road Medical Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
08/04/2019
SUNNYVALE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the [...]
PhaseBio Receives FDA Breakthrough Therapy Designation for PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor
08/04/2019
In Phase 1 clinical trial, PB2452 provided immediate and sustained reversal of ticagrelor antiplatelet effects MALVERN, Pa. and SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS [...]
Zogenix Receives Refusal to File Letter from U.S. Food and Drug Administration for FINTEPLA® New Drug Application
08/04/2019
Zogenix to Host Conference Call Today at 4:30 PM Eastern Time/1:30 PM Pacific Time EMERYVILLE, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare [...]
Zosano Pharma Announces Proposed Public Offering of Common Stock
08/04/2019
FREMONT, Calif., April 08, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of shares of [...]
Kiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs
08/04/2019
HAMILTON, Bermuda, April 08, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic [...]
aTyr Pharma to Present Poster at the American Thoracic Society 2019 International Conference
08/04/2019
ATYR1923 shown to modulate inflammatory and fibrotic processes in multiple interstitial lung disease (ILD) animal models SAN DIEGO, April 08, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics [...]
Zealand Pharma to attend Kempen Life Sciences Conference
08/04/2019
Press release – No. 07 / 2019 Zealand Pharma to attend Kempen Life Sciences Conference Copenhagen, April 08, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the Kempen Life Sciences Conference on [...]
MESA LABS DECLARES QUARTERLY DIVIDEND
08/04/2019
Lakewood, Colo., April 08, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $ [...]
Study of SPR Therapeutics’ Peripheral Nerve Stimulation System Demonstrates Significant and Sustained Relief of Post-Amputation Pain
08/04/2019
SPRINT® 60-day PNS therapy demonstrates 12-month pain relief and 70 percent reduction in opioid use among those taking moderate to high doses CLEVELAND, April 08, 2019 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a [...]

Pages